126 related articles for article (PubMed ID: 35776191)
81. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma.
Cordioli MI; Moraes L; Carvalheira G; Sisdelli L; Alves MT; Delcelo R; Monte O; Longui CA; Cury AN; Cerutti JM
Cancer Med; 2016 Jul; 5(7):1535-41. PubMed ID: 27037835
[TBL] [Abstract][Full Text] [Related]
82. Establishment of a spontaneously transformed cell line (JU-PI) from a myxoinflammatory fibroblastic sarcoma.
Fagerstedt KW; Salonen T; Zhao F; Kytölä S; Böhling T; Andersson LC
Tumour Biol; 2018 May; 40(5):1010428318777936. PubMed ID: 29788803
[TBL] [Abstract][Full Text] [Related]
83. Genetic predictors of MEK dependence in non-small cell lung cancer.
Pratilas CA; Hanrahan AJ; Halilovic E; Persaud Y; Soh J; Chitale D; Shigematsu H; Yamamoto H; Sawai A; Janakiraman M; Taylor BS; Pao W; Toyooka S; Ladanyi M; Gazdar A; Rosen N; Solit DB
Cancer Res; 2008 Nov; 68(22):9375-83. PubMed ID: 19010912
[TBL] [Abstract][Full Text] [Related]
84. The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner.
Joseph EW; Pratilas CA; Poulikakos PI; Tadi M; Wang W; Taylor BS; Halilovic E; Persaud Y; Xing F; Viale A; Tsai J; Chapman PB; Bollag G; Solit DB; Rosen N
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14903-8. PubMed ID: 20668238
[TBL] [Abstract][Full Text] [Related]
85. SKAP2-BRAF fusion and response to an MEK inhibitor in a patient with metastatic melanoma resistant to immunotherapy.
Chew SM; Lucas M; Brady M; Kelly CM
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167970
[TBL] [Abstract][Full Text] [Related]
86. Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
Rankin A; Johnson A; Roos A; Kannan G; Knipstein J; Britt N; Rosenzweig M; Haberberger J; Pavlick D; Severson E; Vergilio JA; Squillace R; Erlich R; Sathyan P; Cramer S; Kram D; Ross J; Miller V; Reddy P; Alexander B; Ali SM; Ramkissoon S
Oncologist; 2021 Jan; 26(1):e153-e163. PubMed ID: 32918774
[TBL] [Abstract][Full Text] [Related]
87. Myxoinflammatory Fibroblastic Sarcoma of Eyeball in an Infant: A Rare Presentation.
Jain E; Kini L; Alaggio R; Ranganathan S
Int J Surg Pathol; 2020 May; 28(3):306-309. PubMed ID: 31594432
[TBL] [Abstract][Full Text] [Related]
88. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
Wangsiricharoen S; Ali SZ; Wakely PE
J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
[TBL] [Abstract][Full Text] [Related]
89. Preliminary results from a prospective trial of preoperative combined BRAF and MEK-targeted therapy in advanced BRAF mutation-positive melanoma.
Johnson AS; Crandall H; Dahlman K; Kelley MC
J Am Coll Surg; 2015 Apr; 220(4):581-93.e1. PubMed ID: 25797743
[TBL] [Abstract][Full Text] [Related]
90. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
91. Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.
Nishio J; Iwasaki H; Nabeshima K; Naito M
Genet Res Int; 2011; 2011():497148. PubMed ID: 22567356
[TBL] [Abstract][Full Text] [Related]
92. Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.
Hernandez MA; Patel B; Hey F; Giblett S; Davis H; Pritchard C
Cell Signal; 2016 Jun; 28(6):561-71. PubMed ID: 26898828
[TBL] [Abstract][Full Text] [Related]
93. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
Packer LM; East P; Reis-Filho JS; Marais R
Pigment Cell Melanoma Res; 2009 Dec; 22(6):785-98. PubMed ID: 19682280
[TBL] [Abstract][Full Text] [Related]
94. Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation.
Jeong WJ; Mo JH; Park MW; Choi IJ; An SY; Jeon EH; Ahn SH
Cancer Biol Ther; 2011 Sep; 12(5):458-65. PubMed ID: 21725210
[TBL] [Abstract][Full Text] [Related]
95. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
96. Novel TEAD1 gene variant in a Serbian family with Sveinsson's chorioretinal atrophy.
Grubisa I; Jankovic M; Nikolic N; Jaksic V; Risimic D; Mavija M; Stamenkovic M; Zlatovic M; Milasin J
Exp Eye Res; 2021 Jun; 207():108575. PubMed ID: 33864784
[TBL] [Abstract][Full Text] [Related]
97. Exploring the potential of VGLL3 methylation as a prognostic indicator for intracranial aneurysm with gender-specific considerations.
Liu Y; Chen S; Zhang E; Xu Y; Deng X; Hu Z; Nie S; Lin Y; Huang Y
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38348744
[TBL] [Abstract][Full Text] [Related]
98. Case report: Primary sarcoma of the mandible with a novel
Zhou P; Liu W; Zheng J; Zhang H; Luo J
Front Oncol; 2024; 14():1369046. PubMed ID: 38606111
[TBL] [Abstract][Full Text] [Related]
99. Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
Nishio J; Nakayama S; Aoki M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
[TBL] [Abstract][Full Text] [Related]
100. Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?
Sparkman BK; Nguyen TVV; Smith SC; Bear HD
J Investig Med High Impact Case Rep; 2023; 11():23247096231205344. PubMed ID: 37840277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
